Indication
Skin and skin structure Fusobacterium infection
A skin and skin structure *Fusobacterium* infection refers to an acute or complicated bacterial infection of the cutaneous and subcutaneous tissues caused by species of the genus *Fusobacterium*, most commonly *Fusobacterium necrophorum* or *Fusobacterium nucleatum*. Read more about Skin and skin structure Fusobacterium infection
66 drugs 59 manufacturers
Drugs that treat it
Common Skin and skin structure Fusobacterium infection therapies.
METRONIDAZOLE
METRONIDAZOLE
METRONIDAZOLE
METRONIDAZOLE
CEFOTETAN (cefotetan disodium)
LIKMEZ (metronidazole)
METRONIDAZOLE (metronidazole in sodium chloride)
METRONIDAZOLE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA skin and skin structure *Fusobacterium* infection refers to an acute or complicated bacterial infection of the cutaneous and subcutaneous tissues caused by species of the genus *Fusobacterium*, most commonly *Fusobacterium necrophorum* or *Fusobacterium nucleatum*.
These obligate anaerobic, Gram-negative bacilli typically colonize mucous membranes and establish soft tissue pathology through traumatic inoculation, bite injuries, surgical disruption, or hematogenous dissemination.
Clinically, affected patients—ranging from healthy individuals following trauma to immunocompromised or diabetic populations—frequently present with localized erythema, warmth, pain, and marked swelling, often progressing to cutaneous abscesses, extensive tissue necrosis, or ulceration.
Pathophysiologically, virulence factors including potent endotoxins and leukotoxins promote severe localized tissue destruction, purulent collection, and a pronounced inflammatory response that may advance to systemic bacteremia if uncontained.
- nih.gov
A skin and skin structure *Fusobacterium* infection refers to an acute or complicated bacterial infection of the cutaneous and subcutaneous tissues caused by species of the genus *Fusobacterium*, most commonly *Fusobacterium necrophorum* or *Fusobacterium nucleatum* These obligate anaerobic, Gram-negative bacilli typically colonize mucous membranes and establish soft tissue pathology through traumatic inoculation, bite injuries, surgical disruption, or hematogenous dissemination Pathophysiologic...
- nih.gov
A skin and skin structure *Fusobacterium* infection refers to an acute or complicated bacterial infection of the cutaneous and subcutaneous tissues caused by species of the genus *Fusobacterium*, most commonly *Fusobacterium necrophorum* or *Fusobacterium nucleatum* Clinically, affected patients—ranging from healthy individuals following trauma to immunocompromised or diabetic populations—frequently present with localized erythema, warmth, pain, and marked swelling, often progressing to cutaneou...
- wikipedia.org
These obligate anaerobic, Gram-negative bacilli typically colonize mucous membranes and establish soft tissue pathology through traumatic inoculation, bite injuries, surgical disruption, or hematogenous dissemination Clinically, affected patients—ranging from healthy individuals following trauma to immunocompromised or diabetic populations—frequently present with localized erythema, warmth, pain, and marked swelling, often progressing to cutaneous abscesses, extensive tissue necrosis, or ulcerat...
- youtube.com
These obligate anaerobic, Gram-negative bacilli typically colonize mucous membranes and establish soft tissue pathology through traumatic inoculation, bite injuries, surgical disruption, or hematogenous dissemination
- fda.gov
Clinically, affected patients—ranging from healthy individuals following trauma to immunocompromised or diabetic populations—frequently present with localized erythema, warmth, pain, and marked swelling, often progressing to cutaneous abscesses, extensive tissue necrosis, or ulceration
Personalize your experience
Follow Skin and skin structure Fusobacterium infection and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.